Non-infective nasal symptom management compositions and methods
AssigneeCMPD Licensing, LLC
InventorJay Richard Ray, II
Life of this patent
Estimating the term…
Abstract
A method of managing non-infective nasal symptoms may include formulating a topical composition for nasal administration. The formulation may include zinc, acetylcysteine, azelastine, one or more probiotics, or a combination thereof. The formulation may also include additional ingredients such as a steroid, poloxamers, or xylitol. Ingredients of the topical composition may be provided in a dry powder format within a capsule for combining with an aqueous diluent at the time of administration. The topical composition may be administered nasally.
Claims11
A method of managing non-infective nasal symptoms, the method comprising:
- topically administering to a nasal cavity of a human a unit dose of a topical nasal composition to manage a non-infective nasal symptom, the topical nasal composition comprising active agents in an aqueous diluent, wherein the active agents include zinc or pharmaceutical salt thereof and a probiotic component, and wherein each unit dose in the topical nasal composition includes between about 1 mg and about 30 mg zinc.
Dependencies are inferred from the claim text.